Niconex Medical Ltd | E-mail:info@niconmedical.com | Phone: +357 22 250804 | Office Hours: M-Fr 09:00-18:00

Niconex Medical Ltd – Regulatory Affairs and Pharmacovigilance Consulting Services

Niconex Medical is a new company providing expertise in local regulatory affairs, pharmacovigilance and medical affairs. The company understands clients’ requirements and engages to ensure high-quality results are delivered in a timely manner to maintain product safety and updated dossiers.


At Niconex Medical we provide local Regulatory Affairs and Pharmacovigilance services to support pharmaceutical companies in the registration and maintenance of medicinal products and medical devices in the Republic of Cyprus. In line with safety obligations, Niconex Medical offers local Pharmacovigilance representation for constant monitoring and safety reporting. Our consulting services include regulatory intelligence available on a regular basis or per request to support in advance planning and preparation aligned with National Competent Authority (NCA) requirements.

Local Regulatory Affairs in compliance with requirements to achieve high-quality results within stringent timelines.

Local Regulatory Affairs Affiliate Service

Niconex Medical acts as local Regulatory Affairs contact for all regulatory matters pertaining to partners’ products including preparation of local dossier, submission of applications e.g. new Marketing Authorization applications, Variations, Renewals, Responses to Questions, Post-Approval commitments e.t.c., align / validate local Product Information, translations, quality control of artworks, any follow-up actions or communications with local Health Authorities with regards to submissions, deficiencies and other national requests. Niconex Medical can support with regulatory intelligence to assist partners in planning and preparing in advance according to local regulations.

Read More

Local Pharmacovigilance services to constantly monitor and maintain safe products in accordance with regulations.

Local Pharmacovigilance Affiliate Service

Provision of local 24/7 responsible person for Pharmacovigilance in line with local requirements to monitor product safety at national level and maintain reporting in timely manner according to required deadlines. Niconex Medical also supports with submission of safety reports, Dear Healthcare Provider (DHCP) letter preparation, submission for approval and dissemination to concerned local parties. In addition, we provide quality control and approval of Educational and / or Promotional Material according to national requirements. If required, we additionally support with scientific and medical HCP communications or visits as partial fulfillment of local Medical Affairs or Medical Science Liaison (MSL) service.

Read More

Support with periodic queries or tasks related to Regulatory Affairs, Pharmacovigilance, Medical Affairs and Market Access.

Consulting Services

Individual services are provided to additionally support periodic requirements of local regulatory intelligence, local NCA fees information, pricing approvals, sales submissions, support with periodic reports, clinical / non-clinical overviews or any other ad hoc individual services e.g. per request DHCP letters, additional document submissions or regulatory reviews and translation services of product texts, additional per request communications with local Authorities.

Read More

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey